SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000886163-18-000095
Filing Date
2018-07-03
Accepted
2018-07-03 18:37:21
Documents
1
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4/A  
1 PRIMARY DOCUMENT edgardoc.xml 4/A 4178
  Complete submission text file 0000886163-18-000095.txt   5566
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11085 NORTH TORREY PINES RD., SUITE 300 LA JOLLA CA 92037
Business Address
Patel Sunil (Reporting) CIK: 0001503062 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33093 | Film No.: 18938904